SEC Form 4 · accession 0001618835-19-000017
Evofem Biosciences, Inc. · EVFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Russell Barrans
Officer — Chief Commercial Officer
Period of report
Feb 25, 2019
Accepted (ET)
Feb 27, 2019 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618835
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 25, 2019 | A | 75,000 | $0.00 | A | 87,541 | D | |
| Common StockF2 | holding | — | — | — | 279 | I | As custodian for child's UTMA account |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2019.
- F2These securities were purchased by the reporting person as custodian for one minor child under the Uniform Transfers to Minors Act. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.